- Home
- CBZ vs ALKS Comparison
CBZ vs ALKS Comparison
Compare CBZ & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- ALKS
- Stock Information
- Founded
- CBZ 1987
- ALKS 1987
- Country
- CBZ United States
- ALKS Ireland
- Employees
- CBZ N/A
- ALKS N/A
- Industry
- CBZ Business Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- CBZ Consumer Discretionary
- ALKS Health Care
- Exchange
- CBZ Nasdaq
- ALKS Nasdaq
- Market Cap
- CBZ 3.9B
- ALKS 4.5B
- IPO Year
- CBZ N/A
- ALKS 1991
- Fundamental
- Price
- CBZ $77.46
- ALKS $27.00
- Analyst Decision
- CBZ Strong Buy
- ALKS Buy
- Analyst Count
- CBZ 1
- ALKS 12
- Target Price
- CBZ $86.00
- ALKS $38.55
- AVG Volume (30 Days)
- CBZ 458.3K
- ALKS 2.0M
- Earning Date
- CBZ 04-24-2025
- ALKS 05-01-2025
- Dividend Yield
- CBZ N/A
- ALKS N/A
- EPS Growth
- CBZ N/A
- ALKS 3.47
- EPS
- CBZ 0.78
- ALKS 2.17
- Revenue
- CBZ $1,813,472,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- CBZ $62.67
- ALKS N/A
- Revenue Next Year
- CBZ $4.85
- ALKS $4.38
- P/E Ratio
- CBZ $99.31
- ALKS $12.27
- Revenue Growth
- CBZ 13.97
- ALKS N/A
- 52 Week Low
- CBZ $62.66
- ALKS $22.90
- 52 Week High
- CBZ $90.13
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- CBZ 54.48
- ALKS 28.10
- Support Level
- CBZ $69.03
- ALKS $26.76
- Resistance Level
- CBZ $80.65
- ALKS $28.03
- Average True Range (ATR)
- CBZ 3.19
- ALKS 1.35
- MACD
- CBZ 0.76
- ALKS -0.37
- Stochastic Oscillator
- CBZ 72.55
- ALKS 18.18
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.